E-cigarette aerosol effects on the cardiovascular system in rodents
E-cigarette aerosol effects on the cardiovascular system in rodents
批准号:
10227000
负责人:
Eric Richard Gross
金额:
$47.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-14 至 2024-08-31
关键词:
AcetaldehydeAcroleinAcuteAddressAdultAerosolsAffectAlcoholsAldehydesBiochemicalBioenergeticsBiological AssayBiological MarkersBiologyBlood capillariesCalciumCardiac MyocytesCardiopulmonaryCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCell DeathCell EnergeticsCell physiologyCellsCigaretteCoupledDNA DamageDiffuseElectrocardiogramElectronic cigaretteEndothelial CellsEnzymesExposure toFormaldehydeFunctional disorderGasesGeneticHeartHeart RateHumanHypoxiaImpairmentIndividualInjuryKnock-in MouseLeadLungMass Spectrum AnalysisMeasuresMembrane PotentialsMetabolismMissionMitochondriaMonitorMusMyocardial InfarctionNational Heart, Lung, and Blood InstitutePhysiologicalPoisonPrimary Cell CulturesProductionProtein ChemistryProteinsPumpResearchResearch PersonnelRodentSystemTelemetryTestingTimeTobaccoToxic effectUmbilical veinVariantWild Type Mouseadductaldehyde dehydrogenasescardiopulmonary systemcardiovascular disorder riskcardiovascular effectscell injurye-cigarette aerosolselectronic cigarette usegenetic variantheart rate variabilityimprovedinnovationresponseskillssmall moleculetoolvapor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY:
E-cigarette aerosol contains reactive aldehydes including acetaldehyde, formaldehyde, and acrolein which are
highly diffusible into cells. These reactive aldehydes, also found in tobacco cigarettes and alcohol, are known
to cause cellular damage that can lead to cardiovascular disease. Further, ~560 million people in the world
carry an aldehyde dehydrogenase 2 (ALDH2) genetic variant, ALDH2*2, that severely limits the metabolism of
reactive aldehydes such as those present in e-cigarette aerosol. Having an ALDH2*2 variant increases the
risk for cardiovascular disease, including cellular damage from a heart attack. However, little is known how the
reactive aldehyde levels in e-cigarette aerosol, coupled with this genetic difference present in reactive
aldehyde metabolism, effect cardiovascular physiology and cellular function.
Here, we will study the effects on the cardiovascular system of e-cigarette aerosol in addition to the individual
reactive aldehydes within e-cigarette aerosol using wild type ALDH2 or ALDH2*2 variant knock-in mice. We
will do so by (AIM 1) exposing wild type ALDH2 mice and ALDH2*2 knock-in mice to e-cigarette aerosol while
monitoring the heart by remote telemetry and quantifying in the heart and lungs the biochemical effects of e-
cigarette aerosol exposure. In isolated adult cardiac myocytes (AIM 2), we will determine in wild type ALDH2
and ALDH2*2 knock-in mice how the individual reactive aldehydes in e-cigarette aerosol alter cellular protein
adduct formation and cellular function. We will also determine how reactive aldehydes at the levels present in
e-cigarette aerosol affect cardiac myocytes subjected to hypoxia-reoxygenation injury. In human umbilical vein
endothelial cells and isolated lung primary endothelial cells (AIM3), we will also determine how reactive
aldehyde exposure causes changes in protein adduct formation and mitochondrial function that leads to
endothelial cell dysfunction.
My research team can bring specific skill-sets and unique tools to this field. We will perform studies to uncover
how e-cigarette aerosol and the reactive aldehyde present within the aerosol effect the cardiovascular system.
In particular, these studies will address the cardiovascular effects of exposure to e-cigarette aerosol and
investigate the effects of e-cigarette aerosol exposure on cardiac myocytes and endothelial cells.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.redox.2022.102369
发表时间:
2022-08
期刊:
REDOX BIOLOGY
影响因子:
11.4
作者:
[Yu, Xuan, Zeng, Xiaocong, Xiao, Feng, Chen, Ri, Sinharoy, Pritam, Gross, Eric R.]
通讯作者:
Gross, Eric R.
Precision medicine for Asian Americans requiring anesthesia
-
批准号:9140955
-
项目类别:
-
资助金额:$37.81万
-
财政年份:2016
-
负责人:Eric Richard Gross
-
依托单位:
Precision medicine for Asian Americans requiring anesthesia
-
批准号:10796752
-
项目类别:
-
资助金额:$5.76万
-
财政年份:2016
-
负责人:Eric Richard Gross
-
依托单位:
Precision medicine for Asian Americans requiring anesthesia
-
批准号:9319777
-
项目类别:
-
资助金额:$37.93万
-
财政年份:2016
-
负责人:Eric Richard Gross
-
依托单位:
Precision medicine for Asian Americans requiring anesthesia
-
批准号:10809415
-
项目类别:
-
资助金额:$1.8万
-
财政年份:2016
-
负责人:Eric Richard Gross
-
依托单位:
Precision medicine for Asian Americans requiring anesthesia
-
批准号:10398192
-
项目类别:
-
资助金额:$43.56万
-
财政年份:2016
-
负责人:Eric Richard Gross
-
依托单位:
Precision medicine for Asian Americans requiring anesthesia
-
批准号:10206639
-
项目类别:
-
资助金额:$43.59万
-
财政年份:2016
-
负责人:Eric Richard Gross
-
依托单位:
Precision medicine for Asian Americans requiring anesthesia
-
批准号:10620647
-
项目类别:
-
资助金额:$43.56万
-
财政年份:2016
-
负责人:Eric Richard Gross
-
依托单位:
Role of the TRPV1 channel in myocardial salvage from ischemia-reperfusion injury
-
批准号:8879189
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2011
-
负责人:Eric Richard Gross
-
依托单位:
Role of the TRPV1 channel in myocardial salvage from ischemia-reperfusion injury
-
批准号:8991133
-
项目类别:
-
资助金额:$2.81万
-
财政年份:2011
-
负责人:Eric Richard Gross
-
依托单位:
Role of the TRPV1 channel in myocardial salvage from ischemia-reperfusion injury
-
批准号:8296613
-
项目类别:
-
资助金额:$13.32万
-
财政年份:2011
-
负责人:Eric Richard Gross
-
依托单位:
Role of the TRPV1 channel in myocardial salvage from ischemia-reperfusion injury
-
批准号:9088496
-
项目类别:
-
资助金额:$23.04万
-
财政年份:2011
-
负责人:Eric Richard Gross
-
依托单位:
Role of the TRPV1 channel in myocardial salvage from ischemia-reperfusion injury
-
批准号:8165163
-
项目类别:
-
资助金额:$13.32万
-
财政年份:2011
-
负责人:Eric Richard Gross
-
依托单位:
Role of the TRPV1 channel in myocardial salvage from ischemia-reperfusion injury
-
批准号:8846820
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Eric Richard Gross
-
依托单位:
国内基金
海外基金
Acrolein调控耳蜗核神经元-胶质细胞网络参与感音神经性耳聋发病机制的研究
-
批准号:81570922
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2015
-
负责人:屈涓
-
依托单位:
acrolein在脊髓损伤后慢性疼痛发生发展中的作用及机制研究
-
批准号:81171052
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:武胜昔
-
依托单位: